Table 2.
SLC6A4 CpG sites | Methylation at birth | Methylation at NICU discharge | ||||||
---|---|---|---|---|---|---|---|---|
LPE VPT infants | HPE VPT infants | LPE VPT infants | HPE VPT infants | |||||
Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
CpG site1 | 1.09 | 0.71 | 1.15 | 0.95 | 1.17 | 0.85 | 1.00 | 0.72 |
CpG site2 | 0.86 | 0.92 | 0.48 | 0.52 | 0.79 | 0.64 | 0.94 | 0.51 |
CpG site3 | 1.54 | 1.06 | 1.16 | 0.82 | 1.24 | 0.92 | 1.30 | 0.64 |
CpG site4 | 1.24 | 0.78 | 1.36 | 0.83 | 1.52 | 0.98 | 1.53 | 0.90 |
CpG site5 | 1.06 | 0.71 | 0.69 | 0.49 | 1.05 | 1.10 | 1.39 | 0.98 |
CpG site6 | 0.86 | 0.63 | 0.59 | 0.70 | 0.49 | 0.42 | 0.80 | 0.45 |
CpG site7 | 0.52 | 0.42 | 0.29 | 0.33 | 0.60 | 0.53 | 0.54 | 0.47 |
CpG site8 | 0.73 | 0.67 | 0.58 | 0.64 | 0.43 | 0.40 | 0.54 | 0.44 |
CpG site9 | 1.80 | 1.10 | 1.68 | 1.17 | 2.25 | 2.09 | 1.79 | 1.05 |
CpG site10 | 1.26 | 1.19 | 1.13 | 1.33 | 1.48 | 2.10 | 1.16 | 1.05 |
CpG site11 | 0.91 | 0.75 | 0.86 | 1.08 | 1.11 | 2.05 | 0.73 | 0.38 |
CpG site12 | 3.17 | 1.38 | 3.14 | 1.31 | 3.44 | 1.61 | 3.48 | 1.07 |
CpG site13 | 0.85 | 0.58 | 0.75 | 0.61 | 0.80 | 0.72 | 0.86 | 0.53 |
CpG site14 | 0.91 | 0.74 | 1.06 | 1.27 | 0.86 | 0.92 | 0.80 | 0.69 |
CpG site15 | 0.55 | 0.58 | 0.72 | 0.90 | 0.72 | 0.67 | 0.63 | 0.46 |
CpG site16 | 1.20 | 0.81 | 0.79 | 0.62 | 1.11 | 0.82 | 1.13 | 0.64 |
CpG site17 | 1.27 | 0.76 | 1.21 | 1.13 | 1.24 | 1.20 | 1.08 | 0.74 |
CpG site18 | 0.94 | 0.95 | 0.87 | 0.81 | 0.99 | 1.03 | 0.75 | 0.59 |
CpG site19 | 0.71 | 0.62 | 0.55 | 0.50 | 0.71 | 0.65 | 0.40 | 0.33 |
CpG site20 | 0.33 | 0.44 | 0.26 | 0.37 | 0.38 | 0.71 | 0.28 | 0.41 |
LPE VPT, Low-pain exposed very preterm infants; HPE VPT, High-pain exposed very preterm infants.